Rectal Cancer Market Analysis and Industry Trends in 2016 - 2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal cancer, high-fat diet consumption and smoking. The most common type of rectal cancer is adenocarcinoma and comprises the majority of all the cases relating to rectal cancer. Other rare forms of rectal cancer are lymphoma, carcinoid, and sarcoma. Rectal bleeding, diarrhea, not being able to vacate the bowel completely, constipation, weight loss, bowel obstruction, small diameter tools, abdominal pain and weakness are some of the most common symptoms of rectal cancer. The various stages of rectal cancer are:Stage I: Tumor is located in the first or second layer of the rectum wall but have not spread out of the rectum itself.
Stage II: Tumor spreads in the mesorectum.
Stage III: Tumor penetrates and spreads in the lymph nodes but not in order parts of the body.
Stage IV: Tumor spreads to different parts of the body, distant organs and tissues such as the lever or the lungs. It has spread outside the rectal region and stage IV is also known as metastatic rectal cancer stage.
Get Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14954
Rectal Cancer Market Segmentation
Based on the diagnosis, the rectal cancer market can be segmented as follows:
Digital rectal examination (DRE)
Rigid proctoscopy
Laboratory tests, i.e., carcinoembryonic antigen (CEA) test, complete blood count etc.
Screening tests, i.e., stool DNA screening, flexible sigmoidoscopy, computed tomography (CT) colonography
Imaging tests, i.e., CT scanning of abdomen, endorectal ultrasonography, pelvic magnetic resonance imaging (MRI)
Before the treatment of a patient diagnosed with rectal cancer begins, three vital points have to be taken into consideration, i.e., the extent to which the tumor has spread, the involvement of lymph nodes and whether the tumor has spread to different parts of the body or not.
Based on the treatments involved, the rectal cancer market can be segmented as follows:
Surgery: Radical resection is the most important surgical treatment for rectal cancer. Others include transanal excision, transanal microsurgery, and endocavity radiotherapy.
Adjuvant medical therapy: Various adjuvant medical management therapies include intraoperative radiation therapy, adjuvant chemotherapy, chemoradiation therapy and radioembolization.
Pharmacotherapy:
Antineoplastic agents (for instance, fluorouracil, leucovorin, panitumumab etc.)
Vaccines (quadrivalent papillomavirus vaccine)
Based on geographical locations, the rectal cancer market can be segmented into four major segments: North America, Europe, Asia-Pacific and Rest of the World (ROW). Out of these four regions, North America dominates the rectal cancer market followed by Europe. The major driving reasons for the growth of rectal cancer market are constantly increasing geriatric population, growing awareness about malignant effects of cancer amongst individuals, and increasing unhealthy lifestyle practices such as smoking and consumption of high fat content food. Asia-Pacific is one of the most lucrative markets for the growth of rectal cancer market and it is continuously growing at a steady rate. The advantageous factors which will contribute towards the augmentation of rectal cancer market in Asia-Pacific are high population density including the geriatric population, rapidly increasing demand for technologically advanced therapeutic treatment, and major government support for improved healthcare infrastructures such as hospitals and clinics.
Various pharmaceutical companies are constantly trying to come up with novel therapeutic drugs and surgeries for the treatment of rectal cancer. Some of the top major players operating in rectal cancer therapeutics market are Eli Lilly and Company, Merck & Co., Inc., Amgen, Inc., Novartis AG, AstraZeneca PLC, Peregrine Pharmaceuticals, Inc., AbbVie, Inc., Nanobiotix, GenVec, Inc.,and many others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Browse Research Report on Global Rectal Cancer Market:
http://www.transparencymarketresearch.com/rectal-cancer-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rectal Cancer Market Analysis and Industry Trends in 2016 - 2024 here
News-ID: 382802 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Rectal
2022-2028 Rectal Irrigation Market | Detailed Report
Global Rectal Irrigation Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5352935
The report provides a…
Rectal Probe Market Demand by 2025: QY Research
Global Rectal Probe Market report is designed in a method that helps readers to acquire a complete knowledge about the overall market scenario for the projected period. This Market report consists of the brief profile of key players in the industry and their upcoming market plans and current developments during the forecasted period 2018 to 2025.
The report of global Rectal Probe market includes the competitive landscape section which provides…
Rectal Cancer - Pipeline Review, H1 2018 by MarketResearchReports.biz
"The Report Rectal Cancer - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Rectal Cancer Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H1 2018, provides an overview of the Rectal Cancer (Oncology) pipeline landscape.
Rectal cancer affects the lower part of the colon, which connects the large…
Rectal Cancer - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Rectal Cancer - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H2 2017, provides an overview of the Rectal Cancer (Oncology) pipeline landscape.
Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk…
Rectal Cancer-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Rectal Cancer-Pipeline Review H2 2017” this report provides an overview of the Rectal Cancer (Oncology) pipeline landscape.
Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a diet mostly from animal sources and personal or…
Rectal Cancer Market Is Expected To Profits by 2016 - 2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal…